The Experts in FDA Regulatory Matters
EAS Consulting Group is a leading provider of regulatory compliance solutions to industries regulated by FDA, USDA, and supporting agencies. Our team of consultants provide expert guidance for all of your regulatory requirements.
LEARN MORE
LEARN MORE
LEARN MORE
LEARN MORE
Learn With Us
Dietary Supplement GMP Compliance Seminar
September 29-30, 2020 • Dallas, TX
Enhance your understanding of compliance requirements under 21 CFR 111, responsibilities of domestic and foreign firms who manufacture, label, pack or hold dietary supplements for sale in the United States, including those involved with the testing, quality control and distribution of supplements.
IFT Webinar – Generally Recognized as Safe? CBD’s Uphill Battle to Answer FDA’s Safety Concerns
May 20, 2020 11:00 AM • 12:00 PM CST
Explore the regulatory and legal landscape of CBD containing products, with a dive into how the CBD industry can begin addressing FDA safety concerns through toxicology in support of filing a successful GRAS submission.
On-demand Webinar – OSHA Lockout-Tagout – Critical Steps to Employee Safety
Presented by Jon Anderson
Protecting employees from serious hazards can be enhanced through OSHA’s Control of Hazardous Energy standard, or Lockout/Tagout. This valuable safety program addresses practices and procedures necessary to disable machinery and prevent the release of potentially hazardous energy and keep our employees safe.
COVID-19 Updates
Food Labeling Challenges in a Pandemic
Under normal circumstances, food producers have many plates to spin in order to comply with food regulations, including food labeling requirements. Most especially, in order to assure accurate food ingredient, allergen and nutrition labeling, manufacturers must be certain they possess the most recent …
EAS COVID-19 Reopening Strategies – Are you Prepared?
As states begin to ease restrictions, the dawn of a new sense of normalcy is on the horizon. For FDA and USDA regulated industries, that new normal requires immense planning and preparation, before...
EAS Client Update: Court Grants FDA’s Request for Extension of PMTA Submission Deadline for Certain Tobacco Products Because of Impacts from COVID-19
In follow up to our recent update on FDA’s motion with the United States District Court for the District of Maryland requesting a 120-day extension of the premarket application deadline for many...
Latest News
EAS Helps Firms Prepare for FDA Inspections Against Intentional Adulteration Rule
FDA began inspections for Intentional Adulteration (IA) Rule components in March 2020, including assessment of Food Defense mitigation strategies, verification of effectiveness and the development...
Food Labeling Challenges in a Pandemic
Under normal circumstances, food producers have many plates to spin in order to comply with food regulations, including food labeling requirements. Most especially, in order to assure accurate food ingredient, allergen and nutrition labeling, manufacturers must be certain they possess the most recent …
Personal Care and Healthy Aging
As the overall population of the U.S. continues to gain longevity, consumers demand personal care products that address the signs and symptoms of aging. Everyone gets older, but no one wants to feel or look older.
Consumers are willing to pay a …
Get the Newsletter
Subscribe to EASeNews and join the nearly 20,000 who receive the monthly EASeNews regulatory newsletter.
EAS – Your Dedicated Consultant for FSVP Services
EAS offers comprehensive services related to FSMA’s FSVP program for both foods and dietary supplements. We can even act as your Qualified Individual. For more information about our services, watch our short video.
Dietary Supplement Good Manufacturing Practice Compliance Short Course
The GMPs dictated in 21 CFR 111 have been in place for over a decade, but the FDA continues to issue numerous Warning Letters for a failure to comply with even the basic tenants of the regulation. EAS Consulting Group’s two-part short course covers the basics of working in a GMP environment including personal hygiene, sanitation, the use of SOPs, and Good Documentation Practices (GDPs). It also addresses the top 5 observations cited in FDA Warning Letters since 2010 which are Specifications, Master Manufacturing and Batch Production Records, Quality Unit responsibilities, Product Complaints, and Holding and Distribution Operations.
Got a Question?
Contact Us Today for a Complimentary Consultation!